MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis

被引:15
|
作者
Chen, Liangyuan [1 ]
Cui, Zhaolei [1 ]
Liu, Yaohua [1 ]
Bai, Ye [1 ]
Lan, Fenghua [1 ]
机构
[1] Fuzhou Gen Hosp, Dept Clin Genet & Expt Med, Fuzhou, Fujian, Peoples R China
关键词
bladder cancer; meta-analysis; microRNA; diagnosis; EXPRESSION PROFILES; TUMOR-MARKERS; URINE; IDENTIFICATION; SENSITIVITY; STATISTICS; TESTS; RNA;
D O I
10.7754/Clin.Lab.2015.150204
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Bladder cancer (BCa) is the fifth most common cancer with significant morbidity and mortality. Recently, numerous studies demonstrated that microRNAs (miRNAs) are emerging as diagnostic biomarkers for BCa. However, the findings in these studies are inconsistent. To systematically assess the potential diagnostic value of miRNAs for BCa, a meta-analysis was performed in this study. Methods: Relevant literature was researched in PubMed, Embase, Cochrane Library, Chinese National Knowledge Infrastructure (CNKI), and WanFang databases up to September 1, 2014. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative LR (NLR), diagnostic odds ratio (DOR), and area under the SROC curve (AUC) value were analyzed by the random-effects model, whose parameters reflected the overall diagnostic performance of miRNAs. Results: Thirty studies from 10 individual publications, including 1019 BCa patients and 690 controls, were included in this meta-analysis. The pooled sensitivity, specificity, PLR, NLR, DOR, and AUC were 0.80 (95% CI: 0.78 - 0.81), 0.74 (95% CI: 0.72 - 0.76), 3.22 (95% CI: 2.68 - 3.87), 0.26 (95% CI: 0.21 - 0.32), 15.20 (95% CI: 10.25 - 22.53) and 0.85, respectively, indicating a moderate diagnostic accuracy for BCa. Moreover, our subgroup analyses showed that analysis of multiple miRNAs (AUC, sensitivity, and specificity of 0.913, 0.86, and 0.80, respectively) yielded a higher diagnostic accuracy than of single miRNAs (AUC, sensitivity, and specificity of 0.84, 0.78, and 0.73, respectively) in BCa diagnosis. In addition, as biomarkers, miRNAs are more suitable for the diagnosis of non-muscle-invasive BCa (NMIBCa) with AUC of 0.84, sensitivity of 0.74, and specificity of 0.77 than muscle-invasive BCa (MIBCa) with AUC of 0.79, sensitivity of 0.73, and specificity of 0.73. Conclusions: The present meta-analysis suggests that miRNAs are potential novel biomarkers for detection of BCa. However, further validation studies are still needed to confirm our findings.
引用
收藏
页码:1101 / 1108
页数:8
相关论文
共 50 条
  • [41] Circulating MicroRNAs as Potential Diagnostic Biomarkers for Diabetic Retinopathy: A Meta-Analysis
    Ma, Lingli
    Wen, Yan
    Li, Zimeng
    Wu, Nan
    Wang, Qing
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [42] Serum microRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma: A meta-analysis
    Chen, Yuping
    Dong, Bingtian
    Huang, Lichun
    Huang, Huibin
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2022, 22 (06) : 862 - 871
  • [43] Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis
    Li, Quan
    Liu, Long
    Li, Weiming
    TUMOR BIOLOGY, 2014, 35 (10) : 10467 - 10478
  • [44] Serum-Derived microRNAs as Prognostic Biomarkers in Osteosarcoma: A Meta-Analysis
    Luo, Huan
    Wang, Peng
    Ye, Hua
    Shi, Jianxiang
    Dai, Liping
    Wang, Xiao
    Song, Chunhua
    Zhang, Jianying
    Li, Jitian
    FRONTIERS IN GENETICS, 2020, 11
  • [45] MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis
    Zhou, Qian
    Liu, Jing
    Quan, Jing
    Liu, Wenlan
    Tan, Hui
    Li, Weiping
    CANCER SCIENCE, 2018, 109 (09): : 2651 - 2659
  • [46] Circulating MicroRNAs as Promising Diagnostic Biomarkers for Patients With Glioma: A Meta-Analysis
    He, Jimin
    Jiang, Yao
    Liu, Liang
    Zuo, Zhihua
    Zeng, Chun
    FRONTIERS IN NEUROLOGY, 2021, 11
  • [47] Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis
    Wu, Nan
    Sun, Hongyan
    Sun, Qian
    Zhang, Fangqing
    Ma, Lingli
    Hu, Yue
    Cong, Xianling
    BMC CANCER, 2023, 23 (01)
  • [48] MicroRNAs as a novel class of diagnostic biomarkers for the detection of osteosarcoma: a meta-analysis
    Liu, Hong
    Li, Ping
    Chen, Liang
    Jian, Chao
    Li, Zonghuan
    Yu, Aixi
    ONCOTARGETS AND THERAPY, 2017, 10 : 5229 - 5236
  • [49] Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis
    Nan Wu
    Hongyan Sun
    Qian Sun
    Fangqing Zhang
    Lingli Ma
    Yue Hu
    Xianling Cong
    BMC Cancer, 23
  • [50] Circulating MicroRNAs as Diagnostic Biomarkers of Clinical Cognitive Impairment: A Meta-Analysis
    Shi, Dan
    Han, Mengyu
    Liu, Weilin
    Tao, Jing
    Chen, Lidian
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2020, 35